Skip to content
healthcare.dev
Get a free key

Rivastigmine Tartrate

NDC 71209-015, Rivastigmine Tartrate, capsule, from Cadila Pharmaceuticals Limited.

Product NDC
71209-015
Status
Listed
Labeler
Cadila Pharmaceuticals Limited
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203844
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71209-015 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVASTIGMINE TARTRATE6 mg/1

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
71209-015-037120900150360 CAPSULE in 1 BOTTLE (71209-015-03)
71209-015-1071209001510500 CAPSULE in 1 BOTTLE (71209-015-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e7e641fe-39bd-4681-a430-6dedeb6d6af5

Use it

Look up 71209-015 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71209-015 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71209-015. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.